Correlation Of Respiratory Rate Level And Trend Evaluation in Heart Failure Patients (CORRELATE-HF)

Boston Scientific

Status: Terminated

Conditions: Heart Failure

Treatments: Device: Cardiac Resynchronization Therapy Defibrillator

Study type: Observational

Funder types: Industry

Identifiers

NCT00758121

CR-CA-091008-H

Details and patient eligibility

About

The objective of the study is to determine if there is any relationship between respiratory rate and Heart Failure events.

Full description

The purpose of the CORRELATE-HF study is to collect RRT data in heart failure patients to gain a better understanding of how respiratory rate changes in relation to all cause clinical events as well as other diagnostic features, including but not limited to, activity level, heart rate, and lead impedance.

Enrollment: 56 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Implanted COGNIS device or future commercially available Boston Scientific CRT-D, that contains the Sensor Trend for Respiratory Rate, with a right ventricular lead and left ventricular lead actively implanted
• Respiratory Sensor programmed "On"
• Classified as having NYHA Class III heart failure documented, in the past 12 months
• Age 18 or above, or of legal age to give informed consent specific to state and national law
• Willing and capable of providing informed consent, participating in all testing associated with this clinical investigation at an approved clinical investigational center and at the intervals defined by this protocol

Exclusion criteria

• Inability or refusal to sign the patient Informed Consent
• Inability or refusal to comply with the follow-up schedule
• Patients that have received routinely scheduled intravenous inotropic therapy as part of their drug regimen within the past 90 days
• Patients prescribed to positive airway pressure therapy
• A life expectancy of less than 180 days, per physician discretion
• Enrolled in any concurrent study without prior written approval from Boston Scientific CRM
• Women who are pregnant or plan to become pregnant in the next twelve months

Trial design

56 participants in 1 patient group

Observation

Description:

Heart failure patients with an implanted CRT-D

Treatment:

Device: Cardiac Resynchronization Therapy Defibrillator